Cargando…
The impact of immunogenicity on therapeutic antibody pharmacokinetics: A preclinical evaluation of the effect of immune complex formation and antibody effector function on clearance
The occurrence of an immune response against therapeutic proteins poses a major risk for the development of biologics and for successful treatment of patients. Generation of anti-drug antibodies (ADAs) can lead to formation of immune complexes (ICs), consisting of drug and ADAs, with potential impac...
Autores principales: | Opolka-Hoffmann, Eugenia, Jordan, Gregor, Otteneder, Michael, Kieferle, Robin, Lechmann, Martin, Winter, Gerhard, Staack, Roland F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726625/ https://www.ncbi.nlm.nih.gov/pubmed/34763611 http://dx.doi.org/10.1080/19420862.2021.1995929 |
Ejemplares similares
-
Generation, Characterization, and Quantitative Bioanalysis of Drug/Anti-drug Antibody Immune Complexes to Facilitate Dedicated In Vivo Studies
por: Hoffmann, Eugenia, et al.
Publicado: (2019) -
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice
por: Egli, Jerome, et al.
Publicado: (2022) -
Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine model
por: Falck, David, et al.
Publicado: (2022) -
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
por: Kamath, Amrita V., et al.
Publicado: (2014) -
Predicting human pharmacokinetics from preclinical data: clearance
por: Yim, Dong-Seok, et al.
Publicado: (2021)